Global Stem Cell Therapy Market was valued at USD 105.24 Million in the year 2017. Global Stem Cell Therapy market is further estimated to grow at a CAGR of 12.33% from 2018 to reach USD 211.39 Million by the year 2023. North America region holds the highest market share in 2017 and the market is also considered as the fastest growing market in the forecasted period. At a country level the U.S. is projected to grow strongly in the coming years. The growth is attributed to the presence of key market players, growing awareness of the stem cell usage in the various application in disorders such as central nervous system disorders, cardiovascular diseases, neurodegenerative diseases, metabolic, eye, and immune system. Osiris Therapeutics, Inc. (U.S.), Holostem Terapie Avanzate S.r.l. (Italy), JCR Pharmaceuticals Co., Ltd. (Japan), NuVasive, Inc. (U.S.), Anterogen Co., Ltd. (South Korea), Pharmicell Co., Ltd. (South Korea), MEDIPOST Co., Ltd. (South Korea), RTI Surgical, Inc. (U.S.), and AlloSource (U.S.) are some of the key players in the Global Stem Cell Therapy market. Organic growth techniques such as expanding global presence along with increasing research and development activities to address the changing demand of the healthcare industry were few techniques adopted by   Read more…